当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析

安图生物

(603658)

  

流通市值:224.74亿  总市值:224.74亿
流通股本:5.71亿   总股本:5.71亿

安图生物(603658)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润2.73亿元,每股收益0.47元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益896985.68万元,未分配利润465309.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1196803.17万元,负债299817.48万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入995,933,663.324,471,202,509.223,380,035,059.482,207,103,914.63
营业总成本746,443,403.963,307,150,305.922,408,355,902.261,583,246,923.9
营业利润303,498,951.951,245,488,947.451,064,101,986.71689,100,045.54
利润总额302,138,440.131,289,056,474.191,054,276,051.5687,185,556.26
净利润273,079,722.471,199,233,279.89969,432,633.28626,977,239.08
其他综合收益-12,112106,410.67-138,346.2870,245.37
综合收益总额273,067,610.471,199,339,690.56969,294,287627,047,484.45
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计6,462,106,370.666,542,768,991.56,134,702,435.565,906,222,469.44
非流动资产合计5,505,925,305.885,332,296,952.475,254,767,410.85,131,480,285.16
资产总计11,968,031,676.5411,875,065,943.9711,389,469,846.3611,037,702,754.6
流动负债合计2,462,122,219.572,659,547,350.972,387,938,078.062,176,562,956.25
非流动负债合计536,052,608.02523,722,740.07515,417,947.94496,642,578.07
负债合计2,998,174,827.593,183,270,091.042,903,356,0262,673,205,534.32
归属于母公司股东权益合计8,876,936,827.168,616,530,318.048,402,371,569.168,286,549,159.64
股东权益合计8,969,856,848.958,691,795,852.938,486,113,820.368,364,497,220.28
负债和股东权益合计11,968,031,676.5411,875,065,943.9711,389,469,846.3611,037,702,754.6
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计1,210,943,311.025,093,794,765.323,754,808,838.972,478,199,530.79
经营活动现金流出小计1,044,604,852.763,784,512,024.22,805,843,424.311,982,708,684.46
经营活动产生的现金流量净额166,338,458.261,309,282,741.12948,965,414.66495,490,846.33
投资活动现金流入小计10,024,513.892,623,053,898.831,427,587,597.82741,454,075.44
投资活动现金流出小计391,016,832.233,808,281,321.692,400,651,358.71,333,209,810.91
投资活动产生的现金流量净额-380,992,318.34-1,185,227,422.86-973,063,760.88-591,755,735.47
筹资活动现金流入小计746,196,189.371,286,955,484.921,062,161,991.98800,000,000
筹资活动现金流出小计767,303,924.892,445,785,430.422,204,222,151.441,840,146,331.62
筹资活动产生的现金流量净额-21,107,735.52-1,158,829,945.5-1,142,060,159.46-1,040,146,331.62
汇率变动对现金及现金等价物的影响3,228,949.871,463,670.6541,957.13143,425.8
现金及现金等价物净增加额-232,532,645.73-1,033,310,956.64-1,165,616,548.55-1,136,267,794.96
期末现金及现金等价物余额219,525,703.08452,058,348.81319,752,756.9349,101,510.49
最新报告期:2025-05-12
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,李婵娟2.212.573.022025-05-12
国金证券袁维2.282.743.302025-05-07
中信证券宋硕,陈竹,曾令鹏2.192.432.752025-04-23
光大证券王明瑞,黎一江2.212.583.012025-04-22
方正证券周超泽2.212.492.802025-04-22
TOP↑